Search results
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 4 hours agoNovavax stock rocketed to a nearly two-year high in June, thanks to a $1.3 billion deal and the...
Novavax (NVAX) Ascends While Market Falls: Some Facts to Note
Zacks via Yahoo Finance· 21 hours agoNovavax (NVAX) closed the most recent trading day at $14.06, moving +1.99% from the previous trading...
COVID-19 is surging. Time to mask up or get a booster? What a Boise medical expert says
Idaho Statesman McClatchy via AOL· 9 hours agoThe Centers for Disease Control and Prevention recommends everyone 6 months and older get an updated...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks· 5 days agoSubject to necessary permissions from the FDA and CDC, Novavax intends to market this updated COVID-19 vaccine in pre-filled syringes by mid-August. Novavax
The FDA Now Wants Fall COVID Vaccines to Target KP.2—But Not All Manufacturers Can Pivot
Verywell Health via Yahoo News· 19 hours agoLess than a week after telling COVID-19 vaccine manufacturers to target the JN.1 variant this fall,...
Short Interest in Novavax, Inc. (NASDAQ:NVAX) Drops By 15.6%
ETF DAILY NEWS· 6 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) was the recipient of a significant decline in short interest during the month of May. As of May 31st, there was short interest ...
A Synergy Of Excellence: Novavax-Mabion Partnership During Unprecedented Times Amid The Covid-19...
BioresearchOnline· 2 days agoNovavax's COVID-19 vaccine, Nuvaxovid, was developed in record time with the support of Mabion, a...
Novavax’s South African Phase IIb COVID-19 vaccine trial likely to reveal results within next...
Pharmaceutical Technology via Yahoo Finance· 3 days agoSouth Africa’s existing regulatory, consent and ethics frameworks around HIV vaccine trial investigations helped with regards to quick initiation and straightforward progress of COVID-19 vaccine trials in the country, the source said.
Jim Cramer Says He's 'Going To Have To Wait' On SoFi, But Recommends This 'Great Little Industrial...
Benzinga· 4 days agoOn CNBC's “Mad Money Lightning Round,” Jim Cramer said he still can't recommend Twilio TWLO. On June...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 1 day agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...